Preventing hospitalisation and early death from chronic heart failure in primary care: a randomised controlled trial of pharmacist led medication review

ISRCTN	ISRCTN70118765
DOI	https://doi.org/10.1186/ISRCTN70118765
Secondary identifying numbers	04/SO701/8

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Plain English summary of protocol

Not provided at time of registration

Mr Richard Lowrie
Scientific

Primary Care Research and Development Directorate
Gartnavel Royal Hospital
1055 Great Western Road
Glasgow
Scotland
G12 OXH
United Kingdom

Phone	+44 (0)141 211 3690
Email	Richard.lowrie@gartnavel.glacomen.scot.nhs.uk

Study design	Randomised controlled trial with cost effectiveness analysis
Primary study design	Interventional
Secondary study design	Randomised controlled trial
Study setting(s)	Other
Study type	Prevention
Participant information sheet	Not available in web format, please use the contact details below to request a patient information sheet
Scientific title
Study objectives	Pharmacists in primary care can prevent hospitalisation and early death through medication review
Ethics approval(s)	2004; Greater Glasgow Primary Care NHS Trust Local Research Ethics Committee
Health condition(s) or problem(s) studied	Chronic heart failure
Intervention	Practices in the control group, in common with intervention group, receive a complete disease register for patients with a diagnosis of chronic heart failure due to left ventricular systolic dysfunction. Control group practices do not receive any further pharmacist led support. Intervention practices receive pharmacist medication review for their patients with heart failure.
Intervention type	Other
Primary outcome measure	Death or heart failure hospitalisations
Secondary outcome measures	Survival times until occurrence of first heart failure hospitalisation or death
Overall study start date	01/05/2004
Completion date	01/06/2009

Participant type(s)	Patient
Age group	Adult
Sex	Both
Target number of participants	2400
Key inclusion criteria	1. Consenting practices 2. Patients with confirmed left ventricular systolic dysfunction (LSVD) providing written consent
Key exclusion criteria	1. Non LVSD 2. Not chronic heart failure 3. Renal failure requiring dialysis 4. Patient under enhanced form of Primary Care
Date of first enrolment	01/05/2004
Date of final enrolment	01/06/2009

Primary Care Research and Development Directorate

Scotland
G12 OXH
United Kingdom

Greater Glasgow Primary Care NHS Trust (UK)
Hospital/treatment centre

Primary Care Research and Development Directorate
Gartnavel Royal Hospital
1055 Great Western Road
Glasgow
Scotland
G12 OXH
Scotland
United Kingdom

"ROR"	https://ror.org/05kdz4d87

Hospital/treatment centre

NHS Glasgow Research and Development

No information available

Intention to publish date
Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
Publication and dissemination plan	Not provided at time of registration
IPD sharing plan

Output type	Details	Date created	Date added	Peer reviewed?	Patient-facing?
Results article	1. results	01/02/2012		Yes	No